Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 5Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1

Interventions

talimogene laherparepvec 1rilotumumab 1lipoplatin 1ganitumab 1cediranib 1Zoledronic Acid 1Verteporfin 1Thoracentesis 1Therapeutics 1Talc 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Spectrum Analysis 1Sodium Chloride 1SPI-77, liposomal 1Radiotherapy, Conformal 1Photochemotherapy 1Nivolumab 1Naproxen 1Immunohistochemistry 1Fluorodeoxyglucose F18 1Fentanyl 1Etoposide 1Drug Therapy 1Doxycycline 1Dihematoporphyrin Ether 1Darbepoetin alfa 1Coal Tar 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pleural Effusion, Malignant × Talc × Clear all
NCT04792970 2023-09-28

Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion

Duke University

Phase 4 Terminated
4 enrolled 14 charts
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡